In yesterday’s Wall Street session, agilon health inc. (NYSE:AGL) shares traded at $17.08, down -3.94% from the previous session.
14 analysts cover agilon health inc. (NYSE:AGL), according to research data. The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $41.00 and a low of $22.00, we find $30.00. Given the previous closing price of $17.78, this indicates a potential upside of 68.73 percent. AGL stock price is now -13.64% away from the 50-day moving average and -20.34% away from the 200-day moving average. The market capitalization of the company currently stands at $7.01B.
Will You Miss Out On This Growth Stock Boom?
A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.
And this is just one of our
5 Best Growth Stocks To Own For 2023.
Sponsored
The stock has received a hold rating from 1 analysts and a buy rating from 13. Brokers who have rated the stock have averaged $30.08 as their price target over the next twelve months.
With the price target of $33, RBC Capital Mkts recently initiated with Outperform rating for agilon health inc. (NYSE: AGL). On September 12, 2022, Goldman recently initiated its ‘Buy’ rating on the stock quoting a target price of $38, while ‘Truist’ rates the stock as ‘Buy’.
In other news, Kornitzer Benjamin, Chief Med. & Quality Officer sold 5,398 shares of the company’s stock on Dec 06. The stock was sold for $95,632 at an average price of $17.72. Upon completion of the transaction, the Chief Med. & Quality Officer now directly owns 10,426 shares in the company, valued at $0.18 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Dec 05, Chief Med. & Quality Officer Kornitzer Benjamin sold 5,398 shares of the business’s stock. A total of $96,079 was realized by selling the stock at an average price of $17.80. This leaves the insider owning 10,426 shares of the company worth $0.18 million. Insiders disposed of 13,331,311 shares of company stock worth roughly $227.7 million over the past 1 year. A total of 0.10% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in AGL stock. A new stake in agilon health inc. shares was purchased by T. ROWE PRICE INVESTMENT MANAGEMENT, INC. during the first quarter worth $46,011,000. NORGES BANK invested $13,972,000 in shares of AGL during the first quarter. In the first quarter, FIRST TRUST ADVISORS LP acquired a new stake in agilon health inc. valued at approximately $11,751,000. ENGLE CAPITAL MANAGEMENT, L.P. acquired a new stake in AGL for approximately $8,301,000. POINT72 ASSET MANAGEMENT, L.P. purchased a new stake in AGL valued at around $7,273,000 in the second quarter.
On Wednesday morning agilon health inc. (NYSE: AGL) stock kicked off with the opening price of $17.67. During the past 12 months, agilon health inc. has had a low of $14.36 and a high of $28.36. As of last week, the company has a debt-to-equity ratio of 0.04, a current ratio of 2.50, and a quick ratio of 2.50. The fifty day moving average price for AGL is $19.78 and a two-hundred day moving average price translates $21.44 for the stock.
The latest earnings results from agilon health inc. (NYSE: AGL) was released for Jun, 2022. According to the Medical Care Facilities Company, earnings per share came in at -$0.05, missing analysts’ expectations of -$0.02 by -0.03. This compares to $0.00 EPS in the same period last year. The net profit margin was -4.30% and return on equity was -9.70% for AGL. The company reported revenue of $694.86 million for the quarter, compared to $458.61 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 51.51 percent. For the current quarter, analysts expect AGL to generate $654.07M in revenue.
agilon health inc.(AGL) Company Profile
agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members and 51,700 medicare fee-for-service beneficiaries. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.
